Cerity Partners
MGNX icon

Cerity Partners’s MacroGenics MGNX Stock Holding History

Cerity Partners’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,137
Closed -$12.3K – 2820
2025
Q2 		$12.3K Buy
+10,137
New +$14.7K ﹤0.01% 2616
2025
Q1 		– Sell
-12,921
Closed -$42K – 2561
2024
Q4 		$42K Sell
12,921
-2,726
-17% -$9.82K ﹤0.01% 2382
2024
Q3 		$51.5K Buy
+15,647
New +$61K ﹤0.01% 2486

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cerity Partners's MGNX Position: Q3 2025 in Review

Cerity Partners sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 10,137 shares — an estimated $12.3K sold.

Cerity Partners first reported a position in MGNX in Q3 2024 and held it in 3 quarters. The position peaked at $51.5K in Q3 2024. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

  • Cerity Partners reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
  • Cerity Partners sold 10,137 MacroGenics shares in Q3 2025, an estimated $12.3K.
  • Cerity Partners first reported a position in MacroGenics in Q3 2024 and held it in 3 quarters.
  • Cerity Partners's MacroGenics position peaked at $51.5K in Q3 2024.
  • 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.